Back
Monte Rosa Therapeutics Stock Price Chart
7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Buy
53
GLUE
Monte Rosa Therapeutics
Last Price:
$5.19
Seasonality Move:
-6.12%
7 Day Trial
ALL ACCESS PASS
$
7
ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GLUE is experiencing buying pressure, which is a positive indicator for future bullish movement.
Monte Rosa Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.83 | Buy |
| 20-day SMA: | 4.8 | Buy |
| 50-day SMA: | 4.53 | Buy |
| 200-day SMA: | 6 | Sell |
| 8-day EMA: | 2.05 | Buy |
| 20-day EMA: | 0.94 | Buy |
| 50-day EMA: | 0.4 | Buy |
| 200-day EMA: | 0.1 | Buy |
Monte Rosa Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.73 | Buy |
| Relative Strength Index (14 RSI): | 67.95 | Buy |
| Chaikin Money Flow: | 453715 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.58 - 5) | Buy |
| Bollinger Bands (100): | (4.13 - 5.87) | Buy |
Monte Rosa Therapeutics Technical Analysis
| Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monte Rosa Therapeutics Stock
Is Monte Rosa Therapeutics Stock a Buy?
-
Monte Rosa Therapeutics share price is 5.29 while GLUE 8-day simple moving average is 4.83, which is a Buy signal.
-
The stock price of GLUE is 5.29 while Monte Rosa Therapeutics 20-day SMA is 4.80, which makes it a Buy.
-
Monte Rosa Therapeutics 50-day simple moving average is 4.53 while GLUE share price is 5.29, making it a Buy technically.
-
GLUE stock price is 5.29 and Monte Rosa Therapeutics 200-day simple moving average is 6.00, creating a Sell signal.
GLUE Technical Analysis vs Fundamental Analysis
Buy
53
Monte Rosa Therapeutics (GLUE)
is a Buy
Is Monte Rosa Therapeutics a Buy or a Sell?
-
Monte Rosa Therapeutics stock is rated a BuyThe current Monte Rosa Therapeutics [GLUE] share price is $5.29. The Score for GLUE is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Monte Rosa Therapeutics Stock Info
Market Cap:
325.4M
Price in USD:
5.29
Share Volume:
549.2K
Monte Rosa Therapeutics 52-Week Range
52-Week High:
12.40
52-Week Low:
3.50
Buy
53
Monte Rosa Therapeutics (GLUE)
is a Buy
Monte Rosa Therapeutics Share Price Forecast
-
What is the Monte Rosa Therapeutics stock price today?The Monte Rosa Therapeutics stock price is 5.29 USD today.
-
Will GLUE stock go up or go down?Monte Rosa Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Monte Rosa Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monte Rosa Therapeutics is not overvalued.
Is Monte Rosa Therapeutics Stock a Buy?
-
Monte Rosa Therapeutics share price is 5.29 while GLUE 8-day exponential moving average is 2.05, which is a Buy signal.
-
The stock price of GLUE is 5.29 while Monte Rosa Therapeutics 20-day EMA is 0.94, which makes it a Buy.
-
Monte Rosa Therapeutics 50-day exponential moving average is 0.40 while GLUE share price is 5.29, making it a Buy technically.
-
GLUE stock price is 5.29 and Monte Rosa Therapeutics 200-day simple moving average is 0.10, creating a Buy signal.
Fundamental Analysis of Monte Rosa Therapeutics
Is Monte Rosa Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.15 per share, an increase this year of $0.82 per share, and a decrease next year of $0.99 per share.
Technical Analysis of Monte Rosa Therapeutics
Should I short Monte Rosa Therapeutics stock?
-
GLUE Moving Average Covergence Divergence (MACD) indicator is 0.73, suggesting Monte Rosa Therapeutics is a Buy
-
Monte Rosa Therapeutics Relative Strength Index (RSI) is 67.95, which suggest Monte Rosa Therapeutics is overbought
-
The Bollinger Bands (25) for Monte Rosa Therapeutics is (4.58 - 5), which suggest Monte Rosa Therapeutics is a Buy
-
The Bollinger Bands (100) for Monte Rosa Therapeutics is (4.13 - 5.87), which suggest Monte Rosa Therapeutics is a Buy
* Monte Rosa Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.